Free Trial

Aemetis (AMTX) Projected to Post Earnings on Thursday

Aemetis logo with Energy background

Aemetis (NASDAQ:AMTX - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of ($0.39) per share and revenue of $59.35 million for the quarter.

Aemetis Price Performance

Shares of AMTX traded down $0.02 during midday trading on Monday, hitting $1.27. The stock had a trading volume of 431,462 shares, compared to its average volume of 698,222. Aemetis has a 1 year low of $1.22 and a 1 year high of $4.73. The stock's 50 day moving average is $1.65 and its 200 day moving average is $2.45. The firm has a market cap of $67.72 million, a PE ratio of -0.56 and a beta of 1.47.

Wall Street Analyst Weigh In

AMTX has been the topic of a number of analyst reports. HC Wainwright reaffirmed a "buy" rating and set a $28.00 target price on shares of Aemetis in a research note on Friday, March 14th. Ascendiant Capital Markets lifted their target price on Aemetis from $18.00 to $19.00 and gave the stock a "buy" rating in a research report on Monday, March 17th. Finally, StockNews.com upgraded shares of Aemetis to a "sell" rating in a report on Wednesday, February 5th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $14.56.

View Our Latest Stock Analysis on AMTX

About Aemetis

(Get Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

See Also

Earnings History for Aemetis (NASDAQ:AMTX)

Should You Invest $1,000 in Aemetis Right Now?

Before you consider Aemetis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.

While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines